Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

CMS to seek Medicare negotiations on Ozempic price

by
January 17, 2025
in Health Care
0
CMS to seek Medicare negotiations on Ozempic price

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation.

CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of the list of drugs for which Medicare will the negotiate the price of in 2025. The list price for a one-month supply of Ozempic costs close to $1,000 without insurance or manufacturer coupons.

According to CMS data, Medicare Part D spending on Ozempic was more than $4.6 billion in 2022.

Ozempic has become emblematic of the explosive enthusiasm for GLP-1 medications in the U.S. Danish pharmaceutical giant Novo Nordisk is the manufacturer of Ozemipc. Its diabetes medication NovoLog was among the first 10 drugs chosen for Medicare negotiation.

The company filed a lawsuit seeking to stop the Medicare negotiation process shortly after NovoLog was named, with a federal judge ruling against the company’s arguments last year.

“Novo Nordisk remains opposed to government price setting through the IRA and has significant concerns about how the law is being implemented by this administration, including aggregating multiple products that individually would not meet the requirements of the statute,” a Novo Nordisk spokesperson said in a statement.

“Even as our IRA lawsuit progresses, we remain committed to working with policymakers to advance solutions to ensure access and affordability for all patients,” they added. “That is why we are deeply concerned about the price-setting process, which could negatively impact patients’ ability to access their medicines and threatens to stifle future scientific development of life-changing medicines for chronic diseases in which there is a real unmet need.”

Semaglutide’s selection was based on a set of criteria in the Inflation Reduction Act. The drug has to be over seven years old; Ozempic just meets this requirement given its approval in December 2017.

A drug also must not have any generic or biosimilars on the market if chosen for Medicare negotiation. Though compounded versions of semaglutide have proliferated in recent years, these products are not considered generic versions of semaglutide and are not approved by the Food and Drug Administration (FDA).

The first round of Medicare negotiations yielded discounts on drugs ranging from 40 to 80 percent, including 76 percent off the list price for NovoLog.

Previous Post

Nutrition labels may come to the front of food packages under FDA proposal

Next Post

The next 15 drugs chosen for Medicare negotiation

Next Post
The next 15 drugs chosen for Medicare negotiation

The next 15 drugs chosen for Medicare negotiation

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    Universal artificial blood could be coming to a hospital near you

    Universal artificial blood could be coming to a hospital near you

    June 6, 2025
    Despite Kennedy’s claims, vaccines have been tested in placebo-controlled studies – nearly 260 of them

    Despite Kennedy’s claims, vaccines have been tested in placebo-controlled studies – nearly 260 of them

    June 5, 2025
    Trump administration rolls back guidance specifying that ERs must offer abortion care when necessary

    Trump administration rolls back guidance specifying that ERs must offer abortion care when necessary

    June 5, 2025

    Trending

    Celiac sufferers can safely kiss bread-eaters, study says

    Celiac sufferers can safely kiss bread-eaters, study says

    May 6, 2025
    Police release photos of suspect in shooting of UnitedHealthcare CEO

    Police release photos of suspect in shooting of UnitedHealthcare CEO

    December 4, 2024
    Former FDA chief counsel says she is anti-abortion, but was pushed out by GOP senator

    Former FDA chief counsel says she is anti-abortion, but was pushed out by GOP senator

    March 27, 2025
    RFK Jr. says he’s ‘not familiar’ with $11b cuts to state and local health departments

    RFK Jr. says he’s ‘not familiar’ with $11b cuts to state and local health departments

    April 9, 2025

    Recent News

    Universal artificial blood could be coming to a hospital near you

    Universal artificial blood could be coming to a hospital near you

    June 6, 2025
    Despite Kennedy’s claims, vaccines have been tested in placebo-controlled studies – nearly 260 of them

    Despite Kennedy’s claims, vaccines have been tested in placebo-controlled studies – nearly 260 of them

    June 5, 2025

    Popular News

    • Universal artificial blood could be coming to a hospital near you
    • Despite Kennedy’s claims, vaccines have been tested in placebo-controlled studies – nearly 260 of them

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.